{"name":"Labo'Life","slug":"labo-life","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"2LPAPI®","genericName":"2LPAPI®","slug":"2lpapi","indication":"Other","status":"marketed"},{"name":"2LALERG","genericName":"2LALERG","slug":"2lalerg","indication":"Other","status":"marketed"},{"name":"2LHERP®","genericName":"2LHERP®","slug":"2lherp","indication":"Other","status":"marketed"},{"name":"2LVERU® or 2LVERU® JUNIOR","genericName":"2LVERU® or 2LVERU® JUNIOR","slug":"2lveru-or-2lveru-junior","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"2LPAPI®","genericName":"2LPAPI®","slug":"2lpapi","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"2LALERG","genericName":"2LALERG","slug":"2lalerg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"2LHERP®","genericName":"2LHERP®","slug":"2lherp","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"2LVERU® or 2LVERU® JUNIOR","genericName":"2LVERU® or 2LVERU® JUNIOR","slug":"2lveru-or-2lveru-junior","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizwJBVV95cUxNeUpIQXNZVy04VUptaGd1dDRMa1YwWjRHQTdsUXg2R1RuV0xlX2g5M1diZFpXNmszX1pIMjJ6SERvcmpaN1RlRmtBSWtITVVMVERMcU55UHVsZzUxTDRoVVhsZ3lpQmJVM2psYzRWZ0ZzbTF1YzJKcUM2WDRXNlJtQTZOb1NXSDJkUW9kZl9iUXE0SDNMX2htMklDd2dGNmlCbkN1c2ZpOVp2VlNzZzItS1ZBSUstclUyQ1IxcHVKYTkwUDQxRl94eVRLZnlRVEN2RGtBbnkyalNINEJucV96Vy1XTXpDWk9IdGdPdWVOVkZadGVvY21hYlRGLTdJSklnNGpuSmNKX0ZwcTJuSmJtbmJhQUtrTmthQkVINmtoWFVUWEU1ZmJZU1IwTklKX3N4Tm5rVGtuN1NMQWFqbFQ1YXh2dVZmWENTemthWm1IZw?oc=5","date":"2026-04-07","type":"regulatory","source":"Barchart.com","summary":"Common Warts Treatment Market Outlook 2034: Insights on Clinical Trials, FDA/EMA/PMDA Approvals, NDA Progress, Therapeutics, Disease Prevalence, Mechanisms, Market Size, Key Companies | DelveInsight -","headline":"Common Warts Treatment Market Outlook 2034: Insights on Clinical Trials, FDA/EMA/PMDA Approvals, NDA Progress, Therapeut","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPQUEwaE1ocmZSemcydEFUdG9fN2VNOWNIRGpobFQtSVBFVGJmczFSR2JlSk11STREUzU4OHZDSlBxSENET1g5QTFjWXZnN2xjSVZzQzFxem5UM1J1WkJKZTRMWGdHOTJ6Z25JODJwWE9tRFItMzJtRnppYjMzSkdBb095NDZCakM0TU1DUm5TRQ?oc=5","date":"2026-03-03","type":"pipeline","source":"New Jersey Business & Industry Association","summary":"HINJ Life Sciences Summit to Focus on NJ’s Pharma and Medtech Future - New Jersey Business & Industry Association","headline":"HINJ Life Sciences Summit to Focus on NJ’s Pharma and Medtech Future - New Jersey Business & Industry Association","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOb0JPS1JMTXl5SENmZ0xYX1oyWm83eFRqYjl5RWxTQW0zbXQ4SXl3WVRkMWVKdVR2akQ2VDVWWW9sUENMSGJLYzZvOUdmRmVkdXlJNXhpMVZrV2tPQm1IeUx4WVdEQ0ZNUHJwemsxSHp1S1BRRUhvRUk1bU1TRVROa3FodTBISVhkcGVSbmVtTjhJN3E1MkhGQklXVmU3b05QSnpIVkxFWHU2NTdRMzRMWkxvV1JpZw?oc=5","date":"2025-09-08","type":"pipeline","source":"McKinsey & Company","summary":"Reimagining life science enterprises with agentic AI - McKinsey & Company","headline":"Reimagining life science enterprises with agentic AI - McKinsey & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNenp2NUcyaklKcUUzYnpLNlk3bHQ3MmRmTzk0VzB4UFMwaHFjUjF1YXAzY2RIVE1xUlJ4M3BwSDhkZnRMOC1ZSF9QSGc0LXhoV2VCcFVacGh5UGRaM3Nsa3ZFUFpWODFHbGRqRWNQcFpmOWJRTHdlZEc1MUNfOFBwdWxMOC1fR0pmVXNpTXlmQjN6UXVpRW15ZXFyUFU4RklMdFNlWTBEVGhuR3dBc2JzVmNjaEVIQmlPc0NvSlh4Q2NacGh6cW1R?oc=5","date":"2025-08-04","type":"pipeline","source":"McKinsey & Company","summary":"The speed-to-market imperative for life sciences capital delivery - McKinsey & Company","headline":"The speed-to-market imperative for life sciences capital delivery - McKinsey & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE50RlBSZExsaHRnal9COFhBcXBjazdBb05BRFpMdmh0SFZlc1lvQTd1eDRMSzdwY2FTM2lxS1pIWUxoY3FmY3Q4ZE5ld2NaTGRHN1k4SWtnYmVoQ0ZsVXVSa3kzWV9CNExTbUdLZjZ4NnU5MjdwSEZ3blQzMA?oc=5","date":"2025-07-21","type":"earnings","source":"JD Supra","summary":"Life Sciences Law Update Key developments for pharma and medical device companies in EU and Germany, France, UK, Italy and Spain in Q2/2025 - JD Supra","headline":"Life Sciences Law Update Key developments for pharma and medical device companies in EU and Germany, France, UK, Italy a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQQjF3XzJjRnotaEkzZmd5VHlnZVRUcHBYSGQxYy1jaXlDeXBBRWsxbUhzZjVFRk95dXBhdVdsTmp2dlpOeWx6YWNCQVhXWnJHQ1dXaFdPSmE3cmxyeW5rNVpSbnA3MlJ4d2lVUEZneklLaWNUU3BUTEZTYTBDWnRXNll0d1RKMXZhdElfd0xfeWxUN1l6WWROTzFUbWNlVVp5bEZjVmRWYXZRcUdLOHV0anhkYmFWRElUeG95LTU0R0tjSVRyX3dKQkxWSU9FYlZZRGc?oc=5","date":"2025-06-18","type":"pipeline","source":"Deloitte","summary":"The Future of Pharmacy - Opportunities & Challenges - Deloitte","headline":"The Future of Pharmacy - Opportunities & Challenges","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPaHdBTUFFd2lsdjUxNElocVNidW9Qd0VRM0xtejFqUGFwSWswMi1pVmlGdldLalZSUVJuM2dNcGpoT3MtQUprYkNfNS1TbFVhdl84SjE0S1V4UTQyNHZkTUN3aG1VRjN0ZTQzYnp0b2RzQ0FYa01WVVA5YkZRNmNnTVdJbVJYYmlaMHlRUW8yaXF5OGh5a0RfRV9WMFZ2LUdHNEpLY3lQcmFhbW1rV3pJRnN3?oc=5","date":"2025-06-18","type":"pipeline","source":"Deloitte","summary":"AI in Pharma and Life Sciences - Deloitte","headline":"AI in Pharma and Life Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE9SMFduNEk3UXpCX05DdGh3ekZvSnJrend4SWZlSi1KZU5vV3l5WV9qY2tPcVRUcWt4VlNNU3hlOFFGZXZabnJFQlliRk9zVHg2Y1Z4Y0FwTjcwNmpmU25teS1qY2paaUt0TDVTeW9jd1pTaEExNllmM1NzTTVEUQ?oc=5","date":"2025-06-16","type":"pipeline","source":"CBRE","summary":"U.S. Life Sciences Talent Trends 2025 - CBRE","headline":"U.S. Life Sciences Talent Trends 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQcWM3Y1VHb0s2dnVzYS0yeVVRd1NzV1JLZXViS0d4clQxUVpfVGd4VVFnNDlhVUZaY24tdTZMak1fWlI5cDlNVUNUaTlOWEdiSjlvR1VaT09yY1hzb0xUTDNaeVVfMHozZERUYUlmeGhKRjV0WmNNUE1IOXZNcm9RakkwMDF0NE9fQVBJbEM3UEowSDllQjN1cG84azdzZzRHeHl2RGhmN3p1U1NtdGpIbUYwdGhKU1djRWZtS1pWaw?oc=5","date":"2025-05-08","type":"trial","source":"PharmaLive","summary":"Salesforce unveils life sciences partner network to accelerate digital labor and data programs - PharmaLive","headline":"Salesforce unveils life sciences partner network to accelerate digital labor and data programs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPYldVbUQwcFIyd1E2RmVRazFWQTZTSUVldTJDeFlDQ2ZIX2h4QzFrMV8xWGVlaU01RmtnRkY2S1dINFVZMVpscXBtUEU0YkJxcGlBTk1PbmxmU3hSbHdIUExUZ1NpeGtfejUzV1lnSzJ4UEJwcW1RaWZyNTlpSFhjcDRoZWw5b0hC?oc=5","date":"2025-04-09","type":"pipeline","source":"BioSpace","summary":"‘Put On Your Life Vest’: Pharma Tariffs Are Coming - BioSpace","headline":"‘Put On Your Life Vest’: Pharma Tariffs Are Coming","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxNY2xOZVBCVkZ4aTEyWGdXRkhoWmhtcUVzWjBFOURTYUhXajBKY2VYdHhjMXRTWEFfWXJ1QWhUeEhXM2M5eVh3YWJ0TlJmbEdfUlVrNVVuem5IUFJXaFNFUTRGYzhWT1NXbWJ1OGJ5S3lyNzhQWnZyZENqNEVrUW9NUmFtTkFkdTJCcXRxV1ZSeE0tM3VxbFlKVnkwUmpYM09JMU5MMFpWdFpPX3dFR2pIQTJLeFcyV29GV3JvMWU4ZWJMdUxaVGc4N0REQ3VqV0pBNUlrS3NCcGpHOTN4SUJkeTdKbHlpUGpLeXpVcjVMSi1mZw?oc=5","date":"2023-05-31","type":"pipeline","source":"Amazon Web Services","summary":"Highlights from the AWS Life Sciences Executive Symposium 2023: Accelerating Pharma Drug Discovery with ML and Generative AI - Amazon Web Services","headline":"Highlights from the AWS Life Sciences Executive Symposium 2023: Accelerating Pharma Drug Discovery with ML and Generativ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxOc3dLSjcyZTdBWGlMV3ZGNVUtUW5mdzRvMDZDbVBHWUZZSUpoQVpVaF9QclZQazV0dHd2Z21VSnRXTFQ0U3VJcHBpRmg3eVFzSnFvLXVBN05YTERJY1V1c0dUZmVzcnk4NFk5akZzcW5CZnlCcFcwa1dMTHVNaDRzWEpZbzE1YTZET0xwMEVWT3YyMzY1cmJFdXRNSkdpSnFRYk1jZ05KLV8xSDJFN1YyVDZOLVZqdGpEamw3T1gzblhsUEpiWGtjY3JVLWtwc0RiYWk2Ui1nV2hoMUVuLTJHTm1TdXBqWnB2UXI3bzJ0Q0pQM1pEZzhNMC1qUkswWndpVlE?oc=5","date":"2023-01-03","type":"pipeline","source":"PR Newswire","summary":"Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division - PR Newswire","headline":"Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"marketed":4},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}